Glioblastoma is the most aggressive primary brain cancer in adults, killing most patients within two years of diagnosis ...

Glioblastoma is the most aggressive form of brain cancer, with survival often measured in months despite treatment. Scientists are mapping its genetic drivers, immune evasion tactics, and treatment ...

Glioblastoma (GBM) is an aggressive type of brain cancer that is known to be very difficult to treat. One reason why this ...

The multi-kinase inhibitor regorafenib did not improve overall survival (OS) compared with standard treatment for patients with newly diagnosed unmethylated or recurrent glioblast ...

Glioblastoma (GBM) is a rare and deadly disease: roughly 12,000 new patients are diagnosed every year in the US, a country of 330 million people. Most GBM patients die within 15 months and fewer than ...

The potential of patient-generated data in glioblastoma (GBM) research represents a paradigm shift in how we approach the study and treatment of the most aggressive and deadly form of brain cancer.

EnGeneIC Limited today announced that the first patient has been dosed in its clinical trial evaluating EnGeneIC’s investigational EGFR-targeted EDV™ (EnGeneIC Dream Vector) therapy in patients with ...

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage ...

UPDATE (Jan. 5, 2017): Since the time of publication, the Riot Games roster database confirms GBM's role-swap to jungle on Team Vitality. Former NRG Esports League of Legends mid laner Lee "GBM" Chang ...

Over 110 LANDs and 220 avatars go live in the metaverse’s most IP-rich auction to date, all powered by GBM’s Win-Win protocol. In a first for The Sandbox, auctions will precede its own platform sale, ...